Moreover, tumours with greater elevations in glutaminase activity significantly correlated with decreased GCN5L1 protein levels (Figure 7F) but not with GLS1 or GLS2 protein levels (Figure 7G,H). The gene discussed is GLS2; the disease is neoplasm.